MedTrace Logo

Acetaminophen for Cancer Pain

NCT00152854 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2016-03-08

No results posted yet for this study

Summary

Many patients with cancer pain have pain not fully controlled on opioids (eg. morphine). The addition of acetaminophen (Tylenol) to opioids in a small study in cancer patients demonstrated better pain control without an increase in side effects. This study will determine if regular acetaminophen improves pain control when added to strong opioids in patients with cancer pain.

Conditions

Interventions

DRUG

Acetaminophen

acetaminophen 1g po qid

DRUG

acetaminophen

acetaminophen 1g po qid for 7 days

DRUG

placebo, sugar pill

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Janette Vardy, MD · University Health Network, University of Toronto

  • David Warr, MD · University Health Network, University of Toronto

  • Ian Tannock, MD, PhD · University Health Network, University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Australia
  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00152854 on ClinicalTrials.gov